{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T23:08:21Z","timestamp":1767913701480,"version":"3.49.0"},"reference-count":11,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T00:00:00Z","timestamp":1685404800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"DOI":"10.3389\/fendo.2023.1220014","type":"journal-article","created":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:44:26Z","timestamp":1685454266000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["Editorial: PCOS: from infertility to pregnancy"],"prefix":"10.3389","volume":"14","author":[{"given":"Stefano","family":"Palomba","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Didier","family":"Dewailly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2023,5,30]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1210\/er.2015-1018","article-title":"Scientific statement on the diagnostic criteria, epidemiology, pathophysiology, and molecular genetics of polycystic ovary syndrome","volume":"36","author":"Dumesic","year":"2015","journal-title":"Endocr Rev"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-m\u00fcllerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum Reprod Update"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deab181","article-title":"Is fertility reduced in ovulatory women with polycystic ovary syndrome","volume":"36","author":"Palomba","year":"2021","journal-title":"Opin Pap Hum Reprod"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2016.11.008","article-title":"Oocyte competence in women with polycystic ovary syndrome","volume":"28","author":"Palomba","year":"2017","journal-title":"Trends Endocrinol Metab"},{"key":"B5","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1093\/humupd\/dmaa051","article-title":"Endometrial function in women with polycystic ovary syndrome: a comprehensive review","volume":"27","author":"Palomba","year":"2021","journal-title":"Hum Reprod Update"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmv029","article-title":"Pregnancy complications in women with polycystic ovary syndrome","volume":"21","author":"Palomba","year":"2015","journal-title":"Hum Reprod Update"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2017.7217","article-title":"Effect of acupuncture and clomiphene in Chinese women with polycystic ovary syndrome: a randomized clinical trial","volume":"317","author":"Wu","year":"2017","journal-title":"JAMA"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2008-0030","article-title":"Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review","volume":"30","author":"Palomba","year":"2009","journal-title":"Endocr Rev"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/dey256","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"33","author":"Teede","year":"2018","journal-title":"Hum Reprod"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1093\/humupd\/dmz029","article-title":"First-line ovulation induction for polycystic ovary syndrome: an individual participant data meta-analysis","volume":"25","author":"Wang","year":"2019","journal-title":"Hum Reprod Update"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/deq361","article-title":"Serum anti-m\u00fcllerian hormone levels are negatively related to follicular output RaTe (FORT) in normo-cycling women undergoing controlled ovarian hyperstimulation","volume":"26","author":"Genro","year":"2011","journal-title":"Hum Reprod"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1220014\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,30]],"date-time":"2023-05-30T13:44:29Z","timestamp":1685454269000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2023.1220014\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,30]]},"references-count":11,"alternative-id":["10.3389\/fendo.2023.1220014"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2023.1220014","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,30]]},"article-number":"1220014"}}